Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae

被引：1
|
作者：
Lee, WK [1 ]
Young, BWY [1 ]
机构：
[1] Pamela Youde Nethersole Eastern Hosp, Dept Paediat & Adolescent Med, Hong Kong Special Adm, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2005年 / 56卷 / 03期
关键词：
antimicrobial therapy; guidelines; prescribing practice;
D O I：
10.1093/jac/dki271
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：603 / 605
页数：4
相关论文
共 50 条
  • [31] Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia
    Fogarty, C
    Torres, A
    Choudhri, S
    Haverstock, D
    Herrington, J
    Ambler, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (11) : 1253 - 1259
  • [32] Adjusted lytA qPCR for improved detection of Streptococcus pneumoniae in community-acquired pneumonia
    Paternotte, Nienke
    Kamies, Bart
    Boersma, W. G.
    Van Der Reijden, W. A.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] Prevalence of Chlamydia pneumoniae infection in Thai children with community-acquired pneumonia
    Likitnukul, S
    Nunthapisud, P
    Prapphal, N
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (08) : 749 - 750
  • [34] Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia
    Mufson, MA
    Stanek, RJ
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (02) : 304 - 306
  • [35] Severe transient cardiomyopathy associated with community-acquired pneumonia caused by Streptococcus pneumoniae
    Gandhi, Tejal
    Wu, Audrey H.
    Aronoff, David M.
    HEART & LUNG, 2008, 37 (05): : 394 - 397
  • [36] Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia
    Strålin, K
    Holmberg, H
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1209 - 1210
  • [37] Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia
    de Jager, C. P. C.
    Wever, P. C.
    Gemen, E. F. A.
    van Oijen, M. G. H.
    van Gageldonk-Lafeber, A. B.
    Siersema, P. D.
    Kusters, G. C. M.
    Laheij, R. J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (10) : 941 - 949
  • [38] Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia
    Ilona den Hartog
    Laura B. Zwep
    Jacqueline J. Meulman
    Thomas Hankemeier
    Ewoudt M. W. van de Garde
    J. G. Coen van Hasselt
    Metabolomics, 20
  • [39] Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia
    Lynch, JP
    Martinez, FJ
    CLINICAL INFECTIOUS DISEASES, 2002, 34 : S27 - S46
  • [40] Clinical and microbiological aspects of acute community-acquired pneumonia due to Streptococcus pneumoniae
    Cardinal-Fernandez, P.
    Garcia Gabarrot, G.
    Echeverria, P.
    Zum, G.
    Hurtado, J.
    Rieppi, G.
    REVISTA CLINICA ESPANOLA, 2013, 213 (02): : 88 - 96
12345